Mechanisms of Myocardial ischemia–reperfusion Injury and the Cytoprotective Role of Minocycline: Scope and Limitations
- 21 January 2015
- journal article
- review article
- Published by Taylor & Francis in Future Cardiology
- Vol. 11 (1) , 61-76
Abstract
Deep insight into the complex mechanisms of myocardial ischemia–reperfusion injury has been attained in the past years. Minocycline is a second-generation tetracycline with US FDA approval for clinical use in various infections. Lately, several noninfectious cytoprotective activities of minocycline have been discovered as well. There now exists encouraging evidence of its protective role in cardiovascular pathology and its activity against myocardial ischemia–reperfusion injury. In this article, an overview of the major mechanisms involved in myocardial ischemia–reperfusion injury is presented. This is followed by an analysis of the mechanisms by which minocycline exerts its cytoprotective role and of studies that have been conducted in order to analyze minocycline, along with a review of the scope and limitations of its role as a cytoprotective agent.Keywords
This publication has 82 references indexed in Scilit:
- Activation of mitochondrial μ-calpain increases AIF cleavage in cardiac mitochondria during ischemia–reperfusionBiochemical and Biophysical Research Communications, 2011
- Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-α/JNKAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Minocycline Protects Cardiac Myocytes Against Simulated Ischemia–Reperfusion Injury by Inhibiting Poly(ADP-ribose) Polymerase-1Journal of Cardiovascular Pharmacology, 2010
- Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for TherapyThe American Journal of Cardiology, 2010
- Cardiac Uptake of Minocycline and Mechanisms for In Vivo CardioprotectionJACC, 2008
- Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion InjuryPhysiological Reviews, 2008
- Minocycline and N -methyl-4-isoleucine cyclosporin (NIM811) mitigate storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transitionHepatology, 2007
- Role of Poly(ADP‐ribose) polymerase 1 (PARP‐1) in Cardiovascular Diseases: The Therapeutic Potential of PARP InhibitorsCardiovascular Drug Reviews, 2007
- Reactive oxygen species trigger ischemic and pharmacological postconditioning: In vivo and in vitro characterizationLife Sciences, 2007
- Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell deathNature, 2005